Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M52,799Revenue $M20,272Net Margin (%)15.1Z-Score2.6
Enterprise Value $M60,942EPS $3.6Operating Margin %19.5F-Score8
P/E(ttm))17.1Cash Flow Per Share $5.9Pre-tax Margin (%)18.0Higher ROA y-yY
Price/Book2.310-y EBITDA Growth Rate %14.6Quick Ratio0.8Cash flow > EarningsY
Price/Sales2.65-y EBITDA Growth Rate %4.8Current Ratio1.2Lower Leverage y-yY
Price/Cash Flow7.3y-y EBITDA Growth Rate %90.2ROA % (ttm)6.5Higher Current Ratio y-yY
Dividend Yield %2.2Insider Buy (3m)0ROE % (ttm)13.2Less Shares Outstanding y-yN
Payout Ratio %38.0Shares Outstanding M852ROI % (ttm)0.2Gross Margin Increase y-yY

Gurus Latest Trades with TEVA

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
TEVAGeorge Soros 2014-12-31 Reduce-0.55%$49.86 - $58.72
($55.77)
$ 61.9810%Reduce -22.01%4,859,966
TEVANWQ Managers 2014-12-31 Reduce-0.39%$49.86 - $58.72
($55.72)
$ 61.9810%Reduce -14.62%4,011,187
TEVAMichael Price 2014-12-31 Reduce-0.36%$49.86 - $58.72
($55.77)
$ 61.9810%Reduce -10.50%447,500
TEVADavid Dreman 2014-12-31 Reduce-0.16%$49.86 - $58.72
($55.77)
$ 61.9810%Reduce -23.89%119,838
TEVAJean-Marie Eveillard 2014-12-31 Add0.14%$49.86 - $58.72
($55.72)
$ 61.9810%Add 72.35%2,448,310
TEVAJohn Keeley 2014-12-31 Reduce-0.01%$49.86 - $58.72
($55.72)
$ 61.9810%Reduce -20.45%37,955
TEVATom Gayner 2014-12-31 Sold Out -0.67%$49.86 - $58.72
($55.72)
$ 61.9810%Sold Out0
TEVAGeorge Soros 2014-09-30 Reduce-0.42%$50.94 - $55.05
($52.93)
$ 61.9815%Reduce -14.32%6,231,722
TEVATom Gayner 2014-09-30 Reduce-0.36%$50.94 - $55.05
($52.93)
$ 61.9815%Reduce -36.02%444,000
TEVAVanguard Health Care Fund 2014-09-30 Reduce-0.27%$50.94 - $55.05
($52.93)
$ 61.9815%Reduce -26.99%5,362,100
TEVANWQ Managers 2014-09-30 Reduce-0.21%$50.94 - $55.05
($52.93)
$ 61.9815%Reduce -7.62%4,698,117
TEVAJean-Marie Eveillard 2014-09-30 Add0.19%$50.94 - $55.05
($52.93)
$ 61.9815%Add 710190.00%1,420,580
TEVAGeorge Soros 2014-06-30 Reduce-1.59%$48.69 - $54.06
($51.09)
$ 61.9818%Reduce -29.45%7,273,240
TEVAVanguard Health Care Fund 2014-06-30 Reduce-0.73%$48.69 - $54.06
($51.09)
$ 61.9818%Reduce -40.54%7,344,400
TEVANWQ Managers 2014-06-30 Reduce-0.56%$48.69 - $54.06
($51.09)
$ 61.9818%Reduce -19.21%5,085,717
TEVARichard Snow 2014-06-30 Add0.21%$48.69 - $54.06
($51.09)
$ 61.9818%Add 6.90%1,826,799
TEVAJames Barrow 2014-06-30 Reduce-0.19%$48.69 - $54.06
($51.09)
$ 61.9818%Reduce -18.50%10,868,770
TEVAKen Heebner 2014-06-30 Sold Out -0.13%$48.69 - $54.06
($51.09)
$ 61.9818%Sold Out0
TEVAGeorge Soros 2014-03-31 Add0.52%$39.88 - $50.22
($45.91)
$ 61.9826%Add 10.67%10,310,041
TEVARichard Snow 2014-03-31 Reduce-0.43%$39.88 - $50.22
($45.91)
$ 61.9826%Reduce -13.55%1,708,890
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

TEVA is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


TEVA: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about TEVA :

Quarterly/Annual Reports about TEVA:

    News about TEVA:

    Articles On GuruFocus.com
    Impax Laboratories Inc. Steps Into Profitable Zone Feb 26 2015 
    Analysts are Bullish on IntelliPharmaceuticals Following Deal with Teva Pharmaceuticals Feb 04 2015 
    Weekly 52-Week Highs Highlight: ITW, ESRX, TEVA, CHD, STI Dec 08 2014 
    Zoetis in a Growing Global Animal Health Industry Dec 03 2014 
    Why Opko Health Is a Better Investment Than Apple Dec 02 2014 
    The Gurus’ Favorite Asian Stocks Sep 07 2014 
    George Soros Reveals His Largest Stake Jul 23 2014 
    George Soros Keeps Buying TEVA, EQT, YPF, EGN, CZR And Keeps Selling GOOGL, BA, MSFT, HAR Jul 16 2014 
    Diamond Hill Capital Comments on Teva Pharmaceutical Industries Ltd Jun 26 2014 
    Diamond Hill Select Fund Commentary – First Quarter 2014 Jun 25 2014 

    More From Other Websites
    PepsiCo, Inc. (PEP), EMC Corporation (EMC): Hedge Fund Tigershark Partners to Close Doors Mar 26 2015
    Ignyta Inc, Horizon Pharma PLC: Biotech Hedgie Kevin Kotler Enjoys Strong Gains Mar 25 2015
    Teva Announces Pricing of €2 Billion of Senior Notes Mar 24 2015
    Teva Announces Pricing of €2 Billion of Senior Notes Mar 24 2015
    STOCKS FALL: Here's what you need to know Mar 24 2015
    Citi thinks pharmaceutical giant Teva is set for a 'material, potentially transformative,... Mar 24 2015
    Why Teva Pharmaceuticals Could Gain 25% Mar 24 2015
    Does Teva Pharmaceutical's New Executive Hint At A Coming M&A Deal? Mar 24 2015
    Teva Migraine Drug Scores In Race With Alder, Lilly Mar 23 2015
    Ohio State tech commercialization chief leaving Mar 23 2015
    Teva Announces New Head of Business Development, Strategy and Innovation Mar 23 2015
    Teva Announces New Head of Business Development, Strategy and Innovation Mar 23 2015
    Teva’s TEV-48125 Meets Primary and Secondary Endpoints in Episodic Migraine Study, Demonstrating... Mar 23 2015
    Teva’s TEV-48125 Meets Primary and Secondary Endpoints in Episodic Migraine Study, Demonstrating... Mar 23 2015
    Check Out 3 Indian Tech Outsourcers Near Buy Points Mar 20 2015
    Farallon Capital Starts New Position in Cubist Pharmaceuticals Mar 20 2015
    Investors Relieved? Akorn Stock Retakes 50-Day Line Mar 18 2015
    Teva Sells Four Oncology Development Assets to Ignyta - Analyst Blog Mar 18 2015
    Investors in health-care stocks get rich as M&A booms Mar 18 2015
    Akorn Leads 5 Drug Stocks Moving After Hours On News Mar 17 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK